Mainz Biomed B.V.
(MYNZ)
undefined
undefined%
At close: undefined
5.20
-1.52%
After-hours Dec 13, 2024, 04:58 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Net Income | -26.30M | -26.39M | -11.69M | -586.89K | -957.05K |
Depreciation & Amortization | 866.41K | 379.80K | 69.93K | 60.46K | 53.04K |
Stock-Based Compensation | 4.01M | 9.82M | 6.43M | - | - |
Other Working Capital | -300.22K | -1.82B | -162.83K | 156.74K | 83.41K |
Other Non-Cash Items | -450.53K | 26.79K | 2.11M | 107.00 | 64.48K |
Deferred Income Tax | - | - | - | - | - |
Change in Working Capital | -64.63K | 1.39M | -138.62K | 57.59K | 423.04K |
Operating Cash Flow | -21.94M | -14.77M | -3.22M | -468.74K | -416.50K |
Capital Expenditures | -1.90M | -658.48K | -16.70K | -9.69K | - |
Acquisitions | - | - | 1.22M | - | - |
Purchase of Investments | - | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | - |
Other Investing Acitivies | -700.00K | - | 1.22M | - | - |
Investing Cash Flow | -1.90M | -658.48K | 1.20M | -9.69K | - |
Debt Repayment | 7.83M | -197.94K | 185.37K | 371.35K | 424.00K |
Common Stock Repurchased | - | - | - | - | - |
Dividend Paid | - | - | - | - | - |
Other Financial Acitivies | - | 275.47K | - | 25.33K | - |
Financial Cash Flow | 14.23M | 23.94M | 10.61M | 396.68K | 424.00K |
Net Cash Flow | -10.07M | 8.41M | 8.60M | -81.02K | -25.94K |
Free Cash Flow | -23.84M | -15.43M | -3.24M | -478.42K | -416.50K |